Literature DB >> 8040270

Interaction of the seed and the soil.

A B Deisseroth, J Koenig.   

Abstract

Mesh：

Substances：

Year:  1994        PMID： 8040270      PMCID： PMC296274          DOI： 10.1172/JCI117321

Source DB:  PubMed          Journal:  J Clin Invest        ISSN： 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  8 in total

1.  Chromosome studies in human leukemia. II. Chronic granulocytic leukemia.

Authors:  P C NOWELL; D A HUNGERFORD
Journal:  J Natl Cancer Inst       Date:  1961-11       Impact factor: 13.506

2.  Interferon-alpha restores normal adhesion of chronic myelogenous leukemia hematopoietic progenitors to bone marrow stroma by correcting impaired beta 1 integrin receptor function.

Authors:  R Bhatia; E A Wayner; P B McGlave; C M Verfaillie
Journal:  J Clin Invest       Date:  1994-07       Impact factor: 14.808

3.  Interferon-alpha restores the deficient expression of the cytoadhesion molecule lymphocyte function antigen-3 by chronic myelogenous leukemia progenitor cells.

Authors:  G Upadhyaya; S C Guba; S A Sih; A P Feinberg; M Talpaz; H M Kantarjian; A B Deisseroth; S G Emerson
Journal:  J Clin Invest       Date:  1991-12       Impact factor: 14.808

4.  Fused transcript of abl and bcr genes in chronic myelogenous leukaemia.

Authors:  E Shtivelman; B Lifshitz; R P Gale; E Canaani
Journal:  Nature       Date:  1985 Jun 13-19       Impact factor: 49.962

5.  Altered adhesive interactions with marrow stroma of haematopoietic progenitor cells in chronic myeloid leukaemia.

Authors:  M Y Gordon; C R Dowding; G P Riley; J M Goldman; M F Greaves
Journal:  Nature       Date:  1987 Jul 23-29       Impact factor: 49.962

6.  Interferon-alpha produces sustained cytogenetic responses in chronic myelogenous leukemia. Philadelphia chromosome-positive patients.

Authors:  M Talpaz; H Kantarjian; R Kurzrock; J M Trujillo; J U Gutterman
Journal:  Ann Intern Med       Date:  1991-04-01       Impact factor: 25.391

7.  Long-term marrow culture of cells from patients with acute myelogenous leukemia. Selection in favor of normal phenotypes in some but not all cases.

Authors:  L Coulombel; C Eaves; D Kalousek; C Gupta; A Eaves
Journal:  J Clin Invest       Date:  1985-03       Impact factor: 14.808

8.  Bcr-Abl oncoproteins bind directly to activators of the Ras signalling pathway.

Authors:  L Puil; J Liu; G Gish; G Mbamalu; D Bowtell; P G Pelicci; R Arlinghaus; T Pawson
Journal:  EMBO J       Date:  1994-02-15       Impact factor: 11.598
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.